Leading researchers join Biogen Idec to advance drug discovery for neurodegenerative disea
Biogen Idec announced that two leading neuroscientists have joined the company to advance its research in neurodegenerative diseases. Christopher Henderson, Ph.D., joins as VP, Neurology. Richard Ransohoff, M.D., joins as senior research fellow, Neuroimmunology. October 23, 2014